Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome (Q33445938)

26 July 2017

Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome (English)

1 reference

hemolytic-uremic syndrome

26 July 2017

1 reference

Ashkenazi S

1

1 reference

26 July 2017

Cleary TG

series ordinal

2

1 reference

26 July 2017

Lopez E

series ordinal

3

1 reference

26 July 2017

Pickering LK

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

The Journal of Pediatrics

26 July 2017

1 reference

26 July 2017

113

1 reference

26 July 2017

6

1 reference

26 July 2017

1008-1014

1 reference

Hemolytic-uremic syndrome. Current concepts and management

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

The Hemolytic-Uremic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Hemolytic-uremic syndrome with shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Haemolytic-uraemic syndrome complicating shigella dystentery in south Indian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Nephron injury in the haemolytic-uraemic syndrome complicating bacillary dysentery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Risk factors for development of hemolytic uremic syndrome during shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Production of Shiga-Like Toxin by Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Antigenic heterogeneity of Escherichia coli verotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Management of hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Treatment of thrombotic thrombocytopenic purpura with intravenous gamma globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Production of Shiga toxin and other cytotoxins by serogroups of Shigella.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

The relation between production of cytotoxin and clinical features in shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Use of staphylococcal protein A as an immunological reagent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Conjugation of antibodies with fluorochromes: modifications to the standard methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROME

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Cytopathic effect of verotoxin on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Escherichia colistrains isolated from pigs with edema disease produce a variant of Shiga-like toxin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchanges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Haemolytic uraemic syndrome: therapeutic effect of plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980572-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(88)80572-9

1 reference

26 July 2017

1 reference